TCL Archive NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015 February 14, 2003
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines? March 19, 2004
TCL Archive HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds March 26, 1982
